Piramal Pharma Q4 net profit jumps

In the corresponding quarter of the previous fiscal, Piramal Pharma posted a net profit of ₹101.3 crore, the company said in a regulatory filing. The company's revenue from operations increased 7.9% to ₹2,754 crore as against ₹2,552.4 crore in the corresponding period of the preceding fiscal. At the operating level, EBITDA was up 5.9% to ₹561 crore in the fourth quarter of this fiscal over ₹529.9 crore in the corresponding period in the previous fiscal.